Treffer: Current Status of Catheter Ablation for Atrial Fibrillation in Japan.

Title:
Current Status of Catheter Ablation for Atrial Fibrillation in Japan.
Authors:
Arita T; Department of Cardiovascular Medicine, The Cardiovascular Institute., Suzuki S; Department of Cardiovascular Medicine, The Cardiovascular Institute., Nagai K; Data Innovation Lab, JMDC Inc., Tanaka T; Data Innovation Lab, JMDC Inc., Nagahama T; Data Innovation Lab, JMDC Inc., Yagi N; Department of Cardiovascular Medicine, The Cardiovascular Institute., Otsuka T; Department of Cardiovascular Medicine, The Cardiovascular Institute., Yamashita T; Department of Cardiovascular Medicine, The Cardiovascular Institute.
Source:
International heart journal [Int Heart J] 2021 Sep 30; Vol. 62 (5), pp. 997-1004. Date of Electronic Publication: 2021 Sep 17.
Publication Type:
Journal Article; Observational Study
Language:
English
Journal Info:
Publisher: International Heart Journal Association Country of Publication: Japan NLM ID: 101244240 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-3299 (Electronic) Linking ISSN: 13492365 NLM ISO Abbreviation: Int Heart J Subsets: MEDLINE
Imprint Name(s):
Original Publication: [Tokyo, Japan] : International Heart Journal Association, [2005]-
Contributed Indexing:
Keywords: AF ablation; Antiarrhythmic drugs; Claims data; Oral anticoagulants; Real-world
Substance Nomenclature:
0 (Anti-Arrhythmia Agents)
0 (Factor Xa Inhibitors)
Entry Date(s):
Date Created: 20210921 Date Completed: 20211011 Latest Revision: 20211011
Update Code:
20250114
DOI:
10.1536/ihj.21-087
PMID:
34544976
Database:
MEDLINE

Weitere Informationen

Catheter ablation for atrial fibrillation (AF) has been an established and frequently utilized approach in a variety of clinical settings. Nevertheless, real-world data about the clinical course of AF patients after initial catheter ablation remain limited, and these are mainly derived from particular registries or selected high-volume centers.In this study, we used health check-ups and insurance claims database from a Japanese insurance organization. The study population was comprised of 1777 patients who underwent catheter ablation for AF before June 2016. During the 3-year follow-up period, 396 (22.3%) patients underwent at least one repeated AF ablation, while 74 (4.2%) underwent two or more repeated ablations. In multivariate Cox regression analysis, longer time after AF diagnosis (7-11 months and ≥12 months versus 1-6 months) (HR, 1.05; 95% CI, 1.01-1.08 and HR, 1.04; 95% CI 1.02-1.07) was independently associated with repeated ablation. The discontinuation rates of OACs and AADs after the first ablation were 26.7% and 63.0% at 3 months and 75.2% and 89.1% at 1 year after the initial ablation, respectively. The former was independently associated with shorter time after AF diagnosis and lower diastolic blood pressure, whereas the latter was independently associated with older age, smaller CHADS <subscript>2</subscript> score, and shorter time after AF diagnosis.We presented real-world data regarding the clinical course of young Japanese AF patients after initial catheter ablation based on a claims database in Japan.